Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

Documenti analoghi

• IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
  di: Debarri, Houria, et al.
  Pubblicazione: (2015)
• MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
  di: Lambert, Juliette, et al.
  Pubblicazione: (2014)
• Tandem duplication PCR: an ultra-sensitive assay for the detection of internal tandem duplications of the FLT3 gene
  di: Lin, Ming-Tseh, et al.
  Pubblicazione: (2013)
• Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
  di: Ferret, Yann, et al.
  Pubblicazione: (2018)
• Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms
  di: Tsai, Harrison K., et al.
  Pubblicazione: (2020)